- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
74.78
+0.78(+1.05%)
Closed
After Hours
74.780.00(0.00%)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
74.05
75.74
52 wk Range
51.79
85.57
TECH Scorecard
Full Analysis
Trading at a high earnings multiple
"Bio-Techne Corp stock price live, this page displays NASDAQ TECH stock exchange data. View the TECH premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Bio-Techne Corp real time stock price chart below.
What Is the Bio-Techne Corp Stock Price Today?
The Bio-Techne Corp stock price today is 74.78.
What Is the Stock Symbol for Bio-Techne Corp?
The stock symbol for Bio-Techne Corp is ""TECH.""
What Stock Exchange Does Bio-Techne Corp Trade On?
Bio-Techne Corp is listed and trades on the NASDAQ stock exchange.
Is Bio-Techne Corp a Good Stock to Buy?
Determining whether Bio-Techne Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the TECH quote. (ISIN: US09073M1045)"
What Is the Bio-Techne Corp Stock Price Today?
The Bio-Techne Corp stock price today is 74.78.
What Is the Stock Symbol for Bio-Techne Corp?
The stock symbol for Bio-Techne Corp is ""TECH.""
What Stock Exchange Does Bio-Techne Corp Trade On?
Bio-Techne Corp is listed and trades on the NASDAQ stock exchange.
Is Bio-Techne Corp a Good Stock to Buy?
Determining whether Bio-Techne Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the TECH quote. (ISIN: US09073M1045)"
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
74.0575.74
52 wk Range
51.7985.57
UnlockTECH Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Technical Analysis
Strong Sell
Price Target
83.09
Upside
+11.11%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Cash flows can sufficiently cover interest payments
- ImmunoScape secures $250,000 G-Rex grant for therapy
- Investing.com
- ImmunoScape secures $250,000 G-Rex grant for therapy
- Investing.com
Bio-Techne Corp Company Profile
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was incorporated in 1976 and is headquartered in Minneapolis, Minnesota.
Compare TECH to Peers and Sector
Metrics to compare | TECH | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipTECHPeersSector | |
|---|---|---|---|---|
P/E Ratio | 70.6x | −1.0x | −0.6x | |
PEG Ratio | −1.75 | −0.19 | 0.00 | |
Price/Book | 5.7x | 2.0x | 2.6x | |
Price / LTM Sales | 10.2x | 3.4x | 3.2x | |
Upside (Analyst Target) | 12.3% | 64.9% | 44.4% | |
Fair Value Upside | Unlock | 14.3% | 6.2% | Unlock |
FAQ
What Is the Bio-Techne (TECH) Stock Price Today?
The Bio-Techne stock price today is 74.78
What Stock Exchange Does Bio-Techne Trade On?
Bio-Techne is listed and trades on the NASDAQ stock exchange.
What Is the Stock Symbol for Bio-Techne?
The stock symbol for Bio-Techne is "TECH."
Does Bio-Techne Pay Dividends? What’s The Current Dividend Yield?
The dividend yield is 0.43%.
What Is the Bio-Techne Market Cap?
As of today, Bio-Techne market cap is 11.86B.
What is Bio-Techne Earnings Per Share?
The Bio-Techne EPS is 1.07.
What Is the Next Bio-Techne Earnings Date?
Bio-Techne will release its next earnings report on 28 Oct 2024.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.